Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:CICHY OTCMKTS:EADSY OTCMKTS:IBDRY OTCMKTS:RHHBY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCICHYChina Construction Bank$22.22-0.5%$21.68$17.15▼$23.00$290.64B0.1278,434 shs42,887 shsEADSYAirbus$48.65-3.6%$49.57$44.00▼$64.35$153.53B1.1765,702 shs654,631 shsIBDRYIberdrola$92.45+0.9%$92.15$69.66▼$96.50$156.19B0.6697,931 shs60,302 shsRHHBYRoche$52.70+1.5%$50.51$37.51▼$60.85$335.73B0.52.62 million shs769,821 shsThe 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCICHYChina Construction Bank-0.80%-2.10%-1.54%+9.30%+25.80%EADSYAirbus+3.25%-0.63%-3.37%-8.19%+10.37%IBDRYIberdrola+0.87%-0.36%-2.30%-0.28%+24.98%RHHBYRoche+0.15%+1.33%+1.19%-12.23%+30.80%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCICHYChina Construction Bank$22.22-0.5%$21.68$17.15▼$23.00$290.64B0.1278,434 shs42,887 shsEADSYAirbus$48.65-3.6%$49.57$44.00▼$64.35$153.53B1.1765,702 shs654,631 shsIBDRYIberdrola$92.45+0.9%$92.15$69.66▼$96.50$156.19B0.6697,931 shs60,302 shsRHHBYRoche$52.70+1.5%$50.51$37.51▼$60.85$335.73B0.52.62 million shs769,821 shsThe 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCICHYChina Construction Bank-0.80%-2.10%-1.54%+9.30%+25.80%EADSYAirbus+3.25%-0.63%-3.37%-8.19%+10.37%IBDRYIberdrola+0.87%-0.36%-2.30%-0.28%+24.98%RHHBYRoche+0.15%+1.33%+1.19%-12.23%+30.80%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCICHYChina Construction Bank 2.00HoldN/AN/AEADSYAirbus 2.27HoldN/AN/AIBDRYIberdrola 2.00HoldN/AN/ARHHBYRoche 2.45Hold$51.50-2.28% DownsideCurrent Analyst Ratings BreakdownLatest IBDRY, RHHBY, CICHY, and EADSY Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/12/2026IBDRYIberdrola Erste Group BankSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold4/24/2026RHHBYRoche Morgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeUnderweight ➝ Equal Weight$46.004/13/2026EADSYAirbus BNP Paribas ExaneSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageNeutral4/10/2026EADSYAirbus UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy4/6/2026RHHBYRoche ArgusSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Buy3/31/2026EADSYAirbus Wells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold3/30/2026EADSYAirbus Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold ➝ Strong Sell3/5/2026EADSYAirbus Erste Group BankSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold3/5/2026EADSYAirbus CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeNeutral ➝ Buy2/27/2026IBDRYIberdrola The Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy ➝ Neutral2/26/2026RHHBYRoche Wolfe ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform(Data available from 5/21/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCICHYChina Construction Bank$181.98B1.60$4.02 per share5.53$36.54 per share0.61EADSYAirbus$83.05B1.85$2.98 per share16.32$9.39 per share5.18IBDRYIberdrola$51.52B3.03$4.32 per share21.39$42.96 per share2.15RHHBYRoche$76.45B4.39$3.66 per share14.40$7.18 per share7.34Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCICHYChina Construction Bank$47.15B$3.666.075.54N/A26.72%9.70%0.77%N/AEADSYAirbus$5.91B$1.8426.4419.621.866.92%20.90%3.88%7/29/2026 (Estimated)IBDRYIberdrola$7.11B$4.0622.7718.792.3113.40%9.88%3.81%7/22/2026 (Estimated)RHHBYRoche$15.55BN/AN/A15.014.26N/AN/AN/A7/23/2026 (Estimated)Latest IBDRY, RHHBY, CICHY, and EADSY EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails4/29/2026Q1 2026CICHYChina Construction Bank$0.9910$0.95-$0.0410$0.95$29.64 billion$30.21 billion4/29/2026Q1 2026IBDRYIberdrola$1.19$1.15-$0.04$1.14$13.62 billion$14.06 billion4/28/2026Q1 2026EADSYAirbus$0.1285$0.22+$0.0915$0.22$14.83 billion$14.80 billion3/27/2026Q4 2025CICHYChina Construction Bank$0.8380$0.85+$0.0120$0.85$24.24 billion$26.13 billion2/25/2026Q4 2025IBDRYIberdrola$0.6730$0.64-$0.0330$0.64$13.76 billion$13.76 billionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthCICHYChina Construction Bank$0.803.58%N/A21.86%N/AEADSYAirbus$0.721.43%N/A39.13%N/AIBDRYIberdrola$1.801.96%N/A44.33%N/ARHHBYRoche$0.971.87%N/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCICHYChina Construction Bank0.730.870.87EADSYAirbus0.531.160.50IBDRYIberdrola0.720.870.78RHHBYRoche0.721.381.12Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCICHYChina Construction BankN/AEADSYAirbus0.25%IBDRYIberdrola0.02%RHHBYRocheN/AInsider OwnershipCompanyInsider OwnershipCICHYChina Construction BankN/AEADSYAirbusN/AIBDRYIberdrolaN/ARHHBYRocheN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCICHYChina Construction Bank376,84713.08 billionN/ANot OptionableEADSYAirbus165,2943.16 billionN/ANot OptionableIBDRYIberdrola40,0001.69 billionN/ANot OptionableRHHBYRoche103,2496.37 billionN/ANot OptionableIBDRY, RHHBY, CICHY, and EADSY HeadlinesRecent News About These CompaniesEXEL Collaborates With MRK for Late-Stage Colorectal Cancer StudyMay 20 at 3:35 PM | zacks.comBAYRY or RHHBY: Which Is the Better Value Stock Right Now?May 20 at 12:40 PM | zacks.comGenentech to Present New Data at ASCO 2026, Reinforcing Giredestrant's Potential to Transform the Treatment Paradigm in Early Breast CancerMay 19 at 1:05 AM | businesswire.comRoche to present new data at ASCO 2026, reinforcing giredestrant's potential to transform the treatment paradigm in early breast cancerMay 19 at 1:00 AM | globenewswire.comRoche Holding AG (RHHBY) Analyst/Investor Day TranscriptMay 18 at 5:01 PM | seekingalpha.comRoche, Medicines Patent Pool sign deal to expand access to influenza drugMay 18 at 12:12 PM | reuters.comRoche's Tecentriq Wins FDA Nod for Label Expansion in Bladder CancerMay 18 at 12:01 PM | zacks.comRoche Holding AG (OTCMKTS:RHHBY) Receives Average Rating of "Hold" from BrokeragesMay 16, 2026 | americanbankingnews.comFDA Approves Genentech’s Tecentriq for Adjuvant Muscle-Invasive Bladder Cancer With ctDNA-Guided TreatmentMay 16, 2026 | finance.yahoo.comRoche gets second European approval for Alzheimer's testMay 12, 2026 | reuters.comRoche receives CE mark for new blood test to detect Alzheimer's pathology: Elecsys® plasma phosphorylated-tau 217 (pTau217)May 12, 2026 | globenewswire.comErste Group Bank Analysts Lift Earnings Estimates for RocheMay 8, 2026 | marketbeat.comF. Hoffmann-La Roche Ltd: Roche enters into a definitive merger agreement to acquire PathAI to transform AI-driven diagnosticsMay 7, 2026 | finanznachrichten.deRoche to Buy PathAI for Up to $1.05 Billion to Bolster AI Diagnostics ToolsMay 7, 2026 | wsj.comSwitzerland's Roche agrees to acquire US-based PathAIMay 7, 2026 | reuters.comRoche enters into a definitive merger agreement to acquire PathAI to transform AI-driven diagnosticsMay 7, 2026 | globenewswire.comFY2026 EPS Estimates for Roche Raised by Erste Group BankApril 30, 2026 | marketbeat.comGenentech to Present Extensive Data Showcasing Its Industry-Leading Ophthalmology Portfolio at ARVO 2026April 30, 2026 | businesswire.comRoche to present extensive data showcasing its industry-leading ophthalmology portfolio at ARVO 2026April 30, 2026 | globenewswire.comBiogen Beats Q1 Earnings Estimates but Cuts 2026 EPS View on M&A CostsApril 29, 2026 | zacks.comRoche Holding AG (OTCMKTS:RHHBY) Sees Large Decrease in Short InterestApril 29, 2026 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeIBDRY, RHHBY, CICHY, and EADSY Company DescriptionsChina Construction Bank OTCMKTS:CICHY$22.22 -0.11 (-0.49%) As of 03:58 PM EasternChina Construction Bank Corporation provides various banking and related financial services to individuals and corporate customers in the People's Republic of China and internationally. It operates through Corporate Finance Business, Personal Finance Business, Treasury and Asset Management Business, and Others segments. The company accepts various deposits, such as foreign currency, all in one accounts, RMB, corporate term and notification, and corporate demand deposits, as well corporate deposits by agreement. Its loan products include personal business, car, and housing loans; and SME, traditional credit, commercial draft, buyer credit, and RMB credit line loans. The company also offers credit cards; physical gold for personal investment and personal gold accounts; foreign exchange services; certificate treasury and savings bonds, securities deposit accounts, and securities services, as well as bank-securities transfer and book-entry treasury bond over the counter transaction services; and wealth management products. In addition, it provides collection, salaries payment, third-party collection and payment, insurance agency, and remittance services; international settlement and financing, and FI services; securities and fund settlement services; guarantee-based, consulting and advising, and factoring services; fund custody services; and e-banking services. Further, the company offers institutional services comprising services for government agencies, social security, banks cooperation, bank-securities cooperation, bank-insurance cooperation, and services for non-banking financial institutions. China Construction Bank Corporation was founded in 1954 and is headquartered in Beijing, the People's Republic of China.Airbus OTCMKTS:EADSY$48.65 -1.80 (-3.57%) As of 03:59 PM EasternAirbus SE, together with its subsidiaries, engages in the design, manufacture, and delivery of aerospace products, services, and solutions worldwide. It operates through three segments: Airbus, Airbus Helicopters, and Airbus Defence and Space. The Airbus segment develops, manufactures, markets, and sells commercial jet passenger aircraft, freighter aircraft, regional turboprop aircraft, and aircraft components, as well as provides aircraft conversion and related services. The Airbus Helicopters segment develops, manufactures, markets, and sells civil and military helicopters; and provides helicopter-related services. The Airbus Defence and Space segment designs, develops, delivers, and supports military air systems and related services. This segment also offers civil and defence space systems for telecommunications, earth observations, navigation, and science and orbital systems; missile and space launcher systems; and services around data processing from platforms, secure communication, and cyber security. The company was formerly known as Airbus Group SE and changed its name to Airbus SE in April 2017. Airbus SE was incorporated in 1998 and is headquartered in Leiden, the Netherlands.Iberdrola OTCMKTS:IBDRY$92.45 +0.84 (+0.92%) As of 03:57 PM EasternIberdrola, S.A. engages in the generation, transmission, distribution, and supply of electricity in Spain, the United Kingdom, the United States, Mexico, Brazil, Germany, France, and Australia. It generates electricity from renewable sources, such as onshore and offshore wind, hydro, photovoltaic, combined cycle gas, and conventional nuclear, as well as through batteries. The company is also involved in the purchase and sale of electricity and gas on wholesale markets; energy retail supply activities, such as gas and electricity, and other products and services, including hydrogen, as well as non-renewable generation; and production of green hydrogen. It has a total installed capacity of 62,871 MW. In addition, the company offers heat pumps, self-consumption, electric mobility, solar, etc. services to residential customers; and management of energy facilities, as well as supplies green H2, industrial heat, etc. to industrial customers. Iberdrola, S.A. was founded in 1840 and is based in Bilbao, Spain.Roche OTCMKTS:RHHBY$52.70 +0.76 (+1.46%) As of 03:59 PM EasternRoche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas NVIDIA Price Pullback? Don’t Count on It, Business Is Accelerating Meta Platforms 10% Layoff Raises a Bigger Question About AI Spending Target Shows Strengths, But Analysts Want to See More Freight Boom: The Hormuz Blockade Payday TJX Companies Fires on All Cylinders With 9% Revenue Growth Analog Devices Provides Much-Needed Pullback: How Low Can It Go? USA Rare Earth Posts Strong Q1 2026 as Massive Serra Vera Deal Looms From Zepbound to Foundayo: Lilly's Latest Results Support Oral GLP-1 Outlook Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
